Lab Interpretation
LDL Pattern A vs Pattern B: What It Means for CV Risk
What's the difference between LDL Pattern A and Pattern B?
What's the difference between LDL Pattern A and Pattern B?
Pattern A means your LDL particles are mostly large and buoyant. These bigger particles tend to float around in the bloodstream without easily sticking to artery walls.
Pattern B is the one that warrants attention. These are smaller, denser LDL particles. They penetrate the arterial wall more easily, oxidize more readily, and get cleared more slowly. That's a bad combination for your arteries.
Pattern B doesn't happen in isolation. It typically shows up alongside metabolic syndrome, insulin resistance, and elevated triglycerides. If you see high TGs with low HDL, think Pattern B until proven otherwise.
(Source: Lamarche B, et al. "Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men." Circulation 1997;95(1):69-75. PMID 8994419)
Does LDL Pattern B actually increase cardiovascular risk?
The evidence points that way. In the ARIC (Atherosclerosis Risk in Communities) study, about 11,400 adults were followed for roughly 11 years. People in the top quarter of small dense LDL cholesterol had about 1.5 times the coronary heart disease risk of those in the bottom quarter, in a model that included established risk factors. The association also held in people whose LDL-C put them at low risk. In the Québec Cardiovascular Study, men with the smallest LDL particles had a higher risk of ischemic heart disease, and adjusting for LDL-C, triglycerides, HDL-C and apoB barely changed that relationship.
Here's what's clinically relevant: a patient can have "normal" LDL-C on a standard panel but still carry Pattern B with elevated LDL-P (particle number). That's hidden risk. A patient can have acceptable cholesterol numbers in fewer large particles, or lower numbers packed into far more small, aggressive particles. The standard panel can't distinguish between these two scenarios.
(Source: Hoogeveen RC, et al. "Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the ARIC study." Arterioscler Thromb Vasc Biol 2014;34(5):1069-77. PMID 24558110)
Who should you test for LDL particle pattern?
Not everyone needs advanced lipid testing. Here's who benefits:
- Metabolic syndrome or prediabetes: the cluster of elevated BP, waist circumference, TGs, and low HDL is a Pattern B warning sign
- Family history of premature CVD: especially when standard panels look unremarkable
- Triglycerides >150 mg/dL with low HDL: a classic metabolic red flag that often travels with Pattern B
- Intermediate ASCVD risk (5% to 20%): Pattern B can be a risk enhancer that tips the scale toward treatment
The test that captures this is an NMR Lipoprofile (or similar advanced panel). It gives you LDL particle number (LDL-P) and particle size distribution, information a standard lipid panel simply can't provide.
How to read LDL-P: in the Framingham Offspring Study, people with low LDL particle numbers had fewer cardiovascular events than people with equally low LDL-C. An LDL-P under 1000 nmol/L sits at about the 20th percentile in that cohort. That is a population percentile, and it is not a guideline treatment target. ApoB gives similar particle-count information; your lab report and current lipid guidelines set the reference ranges.
(Source: Cromwell WC, et al. "LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study: implications for LDL management." J Clin Lipidol 2007;1(6):583-92. PMID 19657464)
Can Pattern B change?
Pattern B tracks closely with insulin resistance, high triglycerides and low HDL, so it is often discussed as a modifiable pattern. Which interventions fit a given patient, and at what intensity, is an individual clinical decision for the treating clinician, guided by current lipid guidelines.
Why do standard lipid panels miss Pattern B?
Your standard panel measures LDL-C, the cholesterol content inside those particles. It doesn't tell you:
- How many particles you're actually carrying (LDL-P)
- How large or small those particles are
- Whether you're dealing with Pattern A or Pattern B
A patient can have LDL-C of 100 mg/dL with either:
- 800 nmol/L large, buoyant particles → lower atherogenic burden
- 1800 nmol/L small, dense particles → substantially higher risk
Same LDL-C number, completely different cardiovascular risk profile. This mismatch between LDL-C and LDL-P is called discordance, and it can hide risk. That's why ApoB and LDL-P matter. They directly measure what the arteries care about.
Quick Reference
| Factor | Pattern A | Pattern B |
|---|---|---|
| Particle size | Large, buoyant | Small, dense |
| Atherogenicity | Lower | Higher |
| Metabolic association | Insulin-sensitive | Insulin-resistant, metabolic syndrome |
| Typical TG/HDL | Normal TG, normal HDL | High TG, low HDL |
The bottom line
LDL Pattern B is a modifiable cardiovascular risk factor that standard lipid panels routinely miss. Don't let a "normal" LDL-C give you or your patient a false sense of security. That's especially true with metabolic syndrome, prediabetes, or family history of early heart disease in the picture.
Consider an NMR Lipoprofile when the clinical picture doesn't match the numbers, and work through the findings with the treating clinician.
Related:
- → Pillar: Cholesterol Particle Size Testing Guide
- → Hub: Functional Medicine Lab Interpretation
- → HANS Pricing
Documenting advanced lipid panel results and building patient education notes takes time. See how HANS, the clinical AI copilot that runs beside your EMR, helps with functional medicine documentation: /pricing
